These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34425246)

  • 41. Lost microbes of COVID-19:
    Hazan S; Stollman N; Bozkurt HS; Dave S; Papoutsis AJ; Daniels J; Barrows BD; Quigley EM; Borody TJ
    BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35483736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of co-circulating pathogens and microbiome from COVID-19 infections.
    Thissen JB; Morrison MD; Mulakken N; Nelson WC; Daum C; Messenger S; Wadford DA; Jaing C
    PLoS One; 2022; 17(12):e0278543. PubMed ID: 36455065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome.
    Shilts MH; Rosas-Salazar C; Strickland BA; Kimura KS; Asad M; Sehanobish E; Freeman MH; Wessinger BC; Gupta V; Brown HM; Boone HH; Patel V; Barbi M; Bottalico D; O'Neill M; Akbar N; Rajagopala SV; Mallal S; Phillips E; Turner JH; Jerschow E; Das SR
    Front Cell Infect Microbiol; 2021; 11():781968. PubMed ID: 35141167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts.
    Hoque MN; Sarkar MMH; Rahman MS; Akter S; Banu TA; Goswami B; Jahan I; Hossain MS; Shamsuzzaman AKM; Nafisa T; Molla MMA; Yeasmin M; Ghosh AK; Osman E; Alam SKS; Uzzaman MS; Habib MA; Mahmud ASM; Crandall KA; Islam T; Khan MS
    Sci Rep; 2021 Dec; 11(1):24042. PubMed ID: 34911967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Description of nasopharyngeal bacterial pathogens associated with different SARS-CoV-2 variants.
    Tchoupou Saha OF; Dubourg G; Yacouba A; Tola R; Raoult D; Lagier JC
    Microb Pathog; 2024 Mar; 188():106561. PubMed ID: 38307371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of circulating bacterial profiles between mild and severe COVID-19 patients.
    Sivapornnukul P; Chitcharoen S; Sawaswong V; Tachaboon S; Dinhuzen J; Srisawat N; Payungporn S
    Exp Biol Med (Maywood); 2023 May; 248(10):866-873. PubMed ID: 36946423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut Microbiota Interplay With COVID-19 Reveals Links to Host Lipid Metabolism Among Middle Eastern Populations.
    Al Bataineh MT; Henschel A; Mousa M; Daou M; Waasia F; Kannout H; Khalili M; Kayasseh MA; Alkhajeh A; Uddin M; Alkaabi N; Tay GK; Feng SF; Yousef AF; Alsafar HS
    Front Microbiol; 2021; 12():761067. PubMed ID: 34803986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
    Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
    Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients.
    Tchoupou Saha OF; Dubourg G; Yacouba A; Bossi V; Raoult D; Lagier JC
    Front Microbiol; 2022; 13():871627. PubMed ID: 35655997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations in the oral microbiome of individuals with a healthy oral environment following COVID-19 vaccination.
    Uehara O; Abiko Y; Nagasawa T; Morikawa T; Hiraki D; Harada F; Kawano Y; Toraya S; Matsuoka H; Paudel D; Shimizu S; Yoshida K; Asaka M; Furuichi Y; Miura H
    BMC Oral Health; 2022 Mar; 22(1):50. PubMed ID: 35241064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct Metagenomic Signatures in the SARS-CoV-2 Infection.
    Liu Y; Zhang H; Tang X; Jiang X; Yan X; Liu X; Gong J; Mew K; Sun H; Chen X; Zou Z; Chen C; Qiu J
    Front Cell Infect Microbiol; 2021; 11():706970. PubMed ID: 34926314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 16S rRNA gene sequencing data of the upper respiratory tract microbiome in the SARS-CoV-2 infected patients.
    Galeeva J; Babenko V; Bakhtyev R; Baklaushev V; Balykova L; Bashkirov P; Bespyatykh J; Blagonravova A; Boldyreva D; Fedorov D; Gafurov I; Gaifullina R; Galova E; Gospodaryk A; Ilina E; Ivanov K; Kharlampieva D; Khromova P; Klimina K; Kolontarev K; Kolyshkina N; Koritsky A; Kuropatkin V; Lazarev V; Manolov A; Manuvera V; Matyushkina D; Morozov M; Moskaleva E; Musarova V; Ogarkov O; Orlova E; Pavlenko A; Petrova A; Pozhenko N; Pushkar D; Rumyantsev A; Rumyantsev S; Rumyantsev V; Rychkova L; Samoilov A; Shirokova I; Sinkov V; Solovieva S; Starikova E; Tikhonova P; Trifonova G; Troitsky A; Tulichev A; Udalov Y; Varizhuk A; Vasiliev A; Veselovsky V; Vereshchagin R; Volnukhin A; Yusubalieva G; Govorun V
    Data Brief; 2022 Feb; 40():107770. PubMed ID: 34977286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
    Xie L; Luo G; Yang Z; Wu WC; Chen J; Ren Y; Zeng Z; Ye G; Pan Y; Zhao WJ; Chen YQ; Hou W; Sun Y; Guo D; Yang Z; Li J; Holmes EC; Li Y; Chen L; Shi M
    J Infect; 2024 Mar; 88(3):106118. PubMed ID: 38342382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiome analysis revealing microbial interactions and secondary bacterial infections in COVID-19 patients comorbidly affected by Type 2 diabetes.
    Al-Emran HM; Rahman S; Hasan MS; Ul Alam R; Islam OK; Anwar A; Jahid MIK; Hossain A
    J Med Virol; 2023 Jan; 95(1):e28234. PubMed ID: 36258280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of ocular and nasopharyngeal microbiome in allergic rhinoconjunctivitis.
    Yau JW; Hou J; Tsui SKW; Leung TF; Cheng NS; Yam JC; Kam KW; Jhanji V; Hon KL
    Pediatr Allergy Immunol; 2019 Sep; 30(6):624-631. PubMed ID: 31132163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal dynamics of the nasopharyngal microbiome in response to SARS-CoV-2 Omicron variant and HIV infection in Kenyan women and their infants.
    Žuštra A; Leonard VR; Holland LA; Hu JC; Mu T; Holland SC; Wu LI; Begnel ER; Ojee E; Chohan BH; Richardson BA; Kinuthia J; Wamalwa D; Slyker J; Lehman DA; Gantt S; Lim ES
    Res Sq; 2024 Apr; ():. PubMed ID: 38699359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association between pneumococcal vaccination, ethnicity, and the nasopharyngeal microbiota of children in Fiji.
    Boelsen LK; Dunne EM; Mika M; Eggers S; Nguyen CD; Ratu FT; Russell FM; Mulholland EK; Hilty M; Satzke C
    Microbiome; 2019 Jul; 7(1):106. PubMed ID: 31311598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.